Open AccessDynamics of Sequencing of Cyclin-Dependent Kinase Inhibitors and Cost Expenditure Analysis in the Management of Metastatic Hormone-Receptor Positive, Human Epidermal Growth Factor 2-Negative Advanced Breast Cancer
Author(s) -
Amol Patel,
Tvsvgk Tilak,
Vineet Gupta,
Atul Batra,
Prashant G. Mehta,
Purvish M. Parikh,
Hemant Malhotra
Publication year - 2019
Publication title -
indian journal of medical and paediatric oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.229
H-Index - 22
eISSN - 0975-2129
pISSN - 0971-5851
DOI - 10.4103/ijmpo.ijmpo_111_19
Subject(s) - fulvestrant , palbociclib , medicine , anastrozole , metastatic breast cancer , oncology , letrozole , exemestane , cyclin dependent kinase , population , progression free survival , breast cancer , cancer , estrogen receptor , aromatase , chemotherapy , environmental health , cell cycle